- Home
- ZDGE vs CELU Comparison
ZDGE vs CELU Comparison
Compare ZDGE & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- CELU
- Stock Information
- Founded
- ZDGE 2008
- CELU 2016
- Country
- ZDGE United States
- CELU United States
- Employees
- ZDGE N/A
- CELU N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- ZDGE Technology
- CELU Health Care
- Exchange
- ZDGE Nasdaq
- CELU Nasdaq
- Market Cap
- ZDGE 50.5M
- CELU 49.9M
- IPO Year
- ZDGE N/A
- CELU N/A
- Fundamental
- Price
- ZDGE $2.04
- CELU $2.25
- Analyst Decision
- ZDGE
- CELU
- Analyst Count
- ZDGE 0
- CELU 0
- Target Price
- ZDGE N/A
- CELU N/A
- AVG Volume (30 Days)
- ZDGE 64.9K
- CELU 240.4K
- Earning Date
- ZDGE 12-16-2024
- CELU 11-07-2024
- Dividend Yield
- ZDGE N/A
- CELU N/A
- EPS Growth
- ZDGE N/A
- CELU N/A
- EPS
- ZDGE N/A
- CELU N/A
- Revenue
- ZDGE $30,204,000.00
- CELU $48,200,000.00
- Revenue This Year
- ZDGE $16.71
- CELU N/A
- Revenue Next Year
- ZDGE $16.10
- CELU $233.89
- P/E Ratio
- ZDGE N/A
- CELU N/A
- Revenue Growth
- ZDGE 10.46
- CELU 225.94
- 52 Week Low
- ZDGE $2.06
- CELU $1.30
- 52 Week High
- ZDGE $5.18
- CELU $7.97
- Technical
- Relative Strength Index (RSI)
- ZDGE 27.52
- CELU 45.08
- Support Level
- ZDGE $2.06
- CELU $2.17
- Resistance Level
- ZDGE $2.80
- CELU $2.43
- Average True Range (ATR)
- ZDGE 0.17
- CELU 0.25
- MACD
- ZDGE -0.05
- CELU -0.01
- Stochastic Oscillator
- ZDGE 7.95
- CELU 47.13
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.